Pune, India -- (SBWire) -- 05/17/2018 --"Global Orthobiologics Market Professional Survey Report to 2018-2023" Purchase This Report by calling Healthcareintelligencemarkets.com.
"Orthobiologics are substances, found in human body, used for faster healing process of injuries such as, broken bones, injured muscles, and ligaments. These substances are made up of substances found in human body. When orthobiologics are used in higher concentration, they help in accelerating healing process. The faster recovery process, reduction in number hospital visits, and accelerated healing are the benefits due to which orthobiologics are gaining prominence."
The orthobiologics market is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.
Download PDF Sample Copy:
https://www.healthcareintelligencemarkets.com/request_sample.php?id=27837
Company Profiled: The Key Players operating in the Orthobiologics Market includes Biomet Inc., Stryker Corporation, Medtronic PLC., Integra Life Sciences Corporation, Zimmer Inc., DePuy Synthes, Exactech Inc., Tornier Inc., Globus Medical Inc., Nuvasive Inc., and Wright Medical Technology Inc.
The key factors driving the growth of the global orthobiologics market are increase in road accidents & sports injuries, rise in obesity rate, awareness among patients & athletes, and rapidly aging population. However, high cost of procedures, stringent regulatory approval procedures for each of the orthobiologic products, and lack of reliable clinical trial data are factors restraining the growth of this market. Advancements in implant technologies and growing demand of biological solutions as compared to mechanical solution create opportunities for its growth.
For More Information:
https://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=27837
The market has been divided into four major regions to provide a regional analysis of the orthobiologics market: North America, Europe, Asia, and Rest of the World. Of these, North America is currently the largest market for orthobiologics owing to a high prevalence of obesity and arthritis, and higher healthcare expenditure in the region. The high share is also attributed to the wide acceptance of orthobiologics products, coupled with launch of new and advanced products in the market. The Asian market is poised to witness the highest growth in the forecasted period due to increasing focus of players in this region, and also as a result of an expanding geriatric population base and increasing number of road accidents.
To Get Reasonable Discount:
https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=27837
Table of Contents
Global Orthobiologics Market Research Report 2018
Chapter 1 Orthobiologics Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Orthobiologics Market Forecast
Global Orthobiologics Market by Product, Application, Type, Industry Verticals & End User - Forecast to 2022
The Report “Orthobiologics Market” provides the Market Size and Forecast for the Different Segments and Geographies for the period of 2017 to 2022